Advertisement

Randomized evaluation of benzathine penicillin V twice daily versus potassium penicillin V three times daily in the treatment of group A streptococcal pharyngitis

  • A. Kaufhold
  • the Pharyngitis Study Group
Article

Abstract

In a randomized, prospective, multicenter study the clinical and bacteriological efficacies of three dosage schedules with two different salts of oral penicillin V suspensions (regimen 1: potassium salt of penicillin V, 50,000 U/kg of body weight per day in three divided doses; regimen 2: benzathine salt of penicillin V, 50,000 U/kg of body weight per day in two divided doses; and regimen 3: benzathine salt of penicillin V, 100,000 U/kg of body weight in two divided doses) for the treatment of streptococcal pharyngitis were evaluated. Children with clinical signs of acute pharyngitis and a positive throat culture for group A beta-hemolytic streptococci (GABHS) were eligible. There was no difference between the treatment groups with respect to the overall clinical success rate. Eradication of the original serotype of GABHS from throat cultures was achieved in 87.1 % (regimen 1), 85.5 % (regimen 2) and 87.7 % (regimen 3) of patients. The incidence of potential drug-related adverse events was significantly higher in patients treated with regimen 3. The results of this and earlier studies strongly suggest that oral penicillin given twice daily should be the recommended treatment for the initial treatment of pharyngitis due to GABHS. Doubling the total daily dose is not beneficial in the usual clinical setting. Because of its favorable pharmacokinetics, the benzathine salt of penicillin V appears to be well suited for a twice-a-day dosage schedule.

Keywords

Divided Dose Pharyngitis Clinical Success Rate Penicillin Versus Streptococcal Pharyngitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dajani AS, Bisno AL, Chung KJ, Durack DT, Gerber MA, Kaplan EL, Millard HD, Randolph MF, Shulman ST, Watanakunakorn C: Prevention of rheumatic fever. A statement for health professionals by the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Circulation 1988, 78: 1082–1086.PubMedGoogle Scholar
  2. 2.
    American Academy of Pediatrics: Group A streptococcal infections. In: Peter E (ed): Red book: report of the Committee on Infectious Diseases, American Academy of Pediatrics, Elk Grove Village, IL, 1991, p. 438–447.Google Scholar
  3. 3.
    Adam D, Handrick W, Kreth HW, Roos R, Scholz H, Stehr K, Wiersbitzky S: Empfehlungen zur Antibiotikatherapie der A-Streptokokken-Tonsillopharyngitis. Münchener Medizinische Wochenschrift 1992, 134: 618–619.Google Scholar
  4. 4.
    Stillerman M: Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis. Pediatric Infectious Disease Journal 1986, 5: 649–654.Google Scholar
  5. 5.
    Kaplan EL, Johnson DR: Eradication of group A streptococci from the upper respiratory tract by amoxycillin with clavulanate after oral penicillin V treatment failure. Journal of Pediatrics 1988, 113: 400–403.PubMedGoogle Scholar
  6. 6.
    Block SL, Hedrick JA, Tyler RD: Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. Pediatric Infectious Disease Journal 1992, 11: 919–925.PubMedGoogle Scholar
  7. 7.
    Pichichero ME, Margolis PA: A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatric Infectious Disease Journal 1991, 10: 275–281.PubMedGoogle Scholar
  8. 8.
    Pichichero ME: Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatric Infectious Disease Journal 1993, 12: 268–274.PubMedGoogle Scholar
  9. 9.
    Markowitz M, Gerber MA, Kaplan EL: Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature. Journal of Pediatrics 1993, 123: 679–685.PubMedGoogle Scholar
  10. 10.
    Shulman ST, Gerber MA, Tanz RR, Markowitz M: Streptococcal pharyngitis: the case for penicillin therapy. Pediatric Infectious Disease Journal 1994, 13: 1–7.PubMedGoogle Scholar
  11. 11.
    Pichichero ME: Explanations and therapies for penicillin failure in streptococcal pharyngitis. Clinical Pediatrics 1992, 31: 642–649.PubMedGoogle Scholar
  12. 12.
    Huang NN, High RH: Effectiveness of penicillin administered orally at intervals of twelve hours. Journal of Pediatrics 1953, 42: 532–536.PubMedGoogle Scholar
  13. 13.
    Breese BB, Disney FA, Talpey WB: Penicillin in streptococcal infections. Total dose and frequency of administration. American Journal of Diseases of Children 1965, 110: 125–130.PubMedGoogle Scholar
  14. 14.
    Rosenstein BJ, Markowitz M, Goldstein E, Kramer I, O'Mansky B, Seidel H, Sigler A, Tramer A: Factors involved in treatment failures following oral penicillin therapy of streptococcal pharyngitis. Journal of Pediatrics 1968, 73: 513–520.PubMedGoogle Scholar
  15. 15.
    Vann RL, Harris BA: Twice-a-day penicillin therapy for streptococcal upper respiratory tract infections. Southern Medical Journal 1972, 65: 203–205.PubMedGoogle Scholar
  16. 16.
    Stillerman M, Isenberg HD, Facklam RR: Streptococcal pharyngitis therapy: comparison of clindamycin palmitate and potassium phenoxymethyl penicillin. Antimicrobial Agents and Chemotherapy 1973, 4: 514–520.PubMedGoogle Scholar
  17. 17.
    Spitzer TQ, Harris BA: Penicillin V therapy for streptococcal pharyngitis: comparison of dosage schedules. Southern Medical Journal 1977, 70: 41–42.PubMedGoogle Scholar
  18. 18.
    Gerber MA, Spadaccini LJ, Wright LL, Deutsch L, Kaplan EL: Twice-daily penicillin in the treatment of streptococcal pharyngitis. American Journal of Diseases of Children 1985, 139: 1145–1148.PubMedGoogle Scholar
  19. 19.
    Krober MS, Weir MR, Themelis NJ, van Hamont JE: Optimal dosing interval for penicillin treatment of streptococcal pharyngitis. Clinical Pediatrics 1990, 29: 646–648.PubMedGoogle Scholar
  20. 20.
    Fyllingen G, Arnesen AR, Ronnevig J: Phenoxymethylpenicillin two or three times daily in bacterial upper respiratory tract infections: a blinded, randomized and controlled clinical study. Scandinavian Journal of Infectious Diseases 1991, 23: 755–761.PubMedGoogle Scholar
  21. 21.
    Holm SE, Roos K, Strömberg A: A randomized study of treatment of streptococcal pharyngotonsillitis with cefadroxil or phenoxymethylpenicillin (penicillin V). Pediatric Infectious Disease Journal 1991, 10, Supplement 10: 68–71.PubMedGoogle Scholar
  22. 22.
    Berger H, Guggenbichler JP: Studies on the oral application of antibiotics. Wiener Medizinische Wochenschrift 1983, Special Issue 1: 10–16.Google Scholar
  23. 23.
    Guggenbichler JP: Fortschritte in der Therapie mit Penicillin im Kindesalter. der Kinderarzt 1992, 23: 1501–1502.Google Scholar
  24. 24.
    Kaufhold A, Lütticken R, Schwien U: Few-minutes tests for the identification of group A streptococci and enterococci with chromogenic substrates. Zentralblatt für Bakteriologie 1989, 272: 191–195.Google Scholar
  25. 25.
    Williams REO: Laboratory diagnosis of streptococcal infections. Bulletin of the World Health Organization 1958, 19: 153–176.PubMedGoogle Scholar
  26. 26.
    Rotta J, Krause RM, Lancefield RC, Everly W, Lackland H: New approaches for the laboratory recognition of M types of group A streptococci. Journal of Experimental Medicine 1971, 134: 1298–1315.PubMedGoogle Scholar
  27. 27.
    Kaltwasser F, Kaltwasser G, Banauch D, Wieczorek L: Nachweis antibakterieller Substanzen im Harn mit Teststreifen. Münchener Medizinische Wochenschrift 1983, 125: 694–696.Google Scholar
  28. 28.
    Schuirmann DJ: A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. Journal of Pharmacokinetics and Biopharmacen 1987, 15; 657–680.Google Scholar
  29. 29.
    Milatovic D, Adam D, Hamilton H, Materman E: Cefprozil versus penicillin V in treatment of streptococcal tonsillopharyngitis. Antimicrobial Agents and Chemotherapy 1993, 37: 1620–1623.PubMedGoogle Scholar
  30. 30.
    Kaplan EL, Gastanaduy AS, Huwe BB: The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. Journal of Laboratory and Clinical Medicine 1981, 98: 326–335.PubMedGoogle Scholar
  31. 31.
    Smith TD, Huskins WC, Kim KS, Kaplan EL: Efficacy of β-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. Journal of Pediatrics 1987, 110: 777–782.PubMedGoogle Scholar
  32. 32.
    Pichichero ME, Disney FA, Aronovitz GH, Talpey WB, Green JL, Francis AB: Randomized, single-blind evaluation of cefadroxil and phenoxymethyl penicillin in the treatment of streptococcal pharyngitis. Antimicrobial Agents and Chemotherapy 1987, 31: 903–906.PubMedGoogle Scholar
  33. 33.
    Gerber MA, Randolph MF, DeMeo K, Feder HM Jr, Kaplan EL: Failure of once-daily penicillin V therapy for streptococcal pharyngitis. American Journal of Diseases of Children 1989, 143: 153–155.PubMedGoogle Scholar
  34. 34.
    Chow AW, Hall CB, Klein JO, Kammer RB, Meyer RD, Remington JS: Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clinical Infectious Diseases 1992, 15, Supplement 1: 62–88.Google Scholar
  35. 35.
    Peter G: Streptococcal pharyngitis: current therapy and criteria for evaluation of new agents. Clinical Infectious Diseases 1992, 14, Supplement 2: 218–223.Google Scholar
  36. 36.
    Stjernquist-Desatnik A, Samuelsson P, Walder M: Penetration of penicillin V to tonsillar surface fluid in healthy individuals and in patients with acute tonsillitis. Journal of Laryngology and Otology 1993, 107: 309–312.PubMedGoogle Scholar
  37. 37.
    Roos K, Grahn E, Ekedahl C, Holm SE: Pharmacokinetics of phenoxymethylpenicillin in tonsils. Scandinavian Journal of Infectious Diseases 1986, 18: 125–130.PubMedGoogle Scholar
  38. 38.
    Strömberg A, Friberg U, Cars O: Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid. European Journal of Clinical Microbiology 1987, 6: 525–529.PubMedGoogle Scholar
  39. 39.
    Bass JW: Antibiotic management of group A streptococcal pharyngotonsillitis. Pediatric Infectious Disease Journal 1991, 10, Supplement 10: 43–49.Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1995

Authors and Affiliations

  • A. Kaufhold
    • 1
  • the Pharyngitis Study Group
  1. 1.Institute of Medical MicrobiologyTechnical University (RWTH)AachenGermany

Personalised recommendations